STOCK TITAN

Palatin Technologies: Ikarian reports 6.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Palatin Technologies Inc. (PTN) is the subject of a Schedule 13G in which Ikarian Capital, LLC and Neil Shahrestani each report beneficial ownership of the same 123,132 common shares, or 6.9% of the class. Both report shared voting and dispositive power over the position, with no sole voting or dispositive power.

The shares are held by Ikarian Healthcare Master Fund, L.P. and certain separately managed accounts. Ikarian Capital is the Fund’s investment manager and sub-adviser to the managed accounts; Shahrestani may be deemed to indirectly beneficially own the securities through his indirect control of Ikarian Capital.

Beneficially owned shares 123,132 shares Same reported position for Ikarian Capital and Neil Shahrestani
Percent of class 6.9% Reported for each reporting person
Common shares outstanding 1,780,939 shares As of September 25, 2026; basis for the reported ownership percentage
beneficial ownership regulatory
"may be deemed to have beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Power regulatory
"Shared Voting Power 123,132.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 123,132.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PTN shares did Ikarian Capital and Neil Shahrestani report owning?

Each reported beneficial ownership of 123,132 shares, or 6.9% of the class. The reported amounts reflect the same position, held by the Fund and certain separately managed accounts.

What share count was used to calculate the 6.9% PTN ownership?

The calculation was based on 1,780,939 common shares outstanding as of September 25, 2026, as disclosed in Palatin’s annual report filed on September 28, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





696077601

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The figures in Items 6, 8, and 9 represent Common Stock, par value $.01 per share ("Common Stock") of Palatin Technologies, Inc. (the "Issuer") held by Ikarian Healthcare Master Fund, L.P., a Cayman Islands exempted limited partnership (the "Fund"), and certain separately managed accounts. See Item 2 for more information. (2) The figure in Item 11 is based upon 1,780,939 Common Stock of the Issuer outstanding as of September 25, 2026, as disclosed in the Issuer's annual report on Form 10-K, filed with the U.S. Securities and Exchange Commission (the "SEC") on September 28, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The figures in Items 6, 8, and 9 represent Common Stock of the Issuer held by the Fund and certain separately managed accounts. See Item 2 for more information. (2) The figure in Item 11 is based upon 1,780,939 Common Stock of the Issuer outstanding as of September 25, 2026, as disclosed in the Issuer's annual report on Form 10-K, filed with the SEC on September 28, 2026.


SCHEDULE 13G



Ikarian Capital, LLC
Signature:/s/ Neil Shahrestani
Name/Title:Neil Shahrestani, Sole Manager
Date:11/16/2026
Neil Shahrestani
Signature:/s/ Neil Shahrestani
Name/Title:Neil Shahrestani
Date:11/16/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (filed herewith).

Keep reading